PP219 – Development and Validation of a Novel Prognostic Nomogram for COPD patients with Pulmonary Hypertension

Dansha Zhou, China

Source: ERS Lung Science Conference 2021
Number: 87
Disease area: Airway diseases


Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dansha Zhou, China. PP219 – Development and Validation of a Novel Prognostic Nomogram for COPD patients with Pulmonary Hypertension. ERS Lung Science Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Pulmonary Hypertension in Pulmonary tuberculosis- A Prognostic Indicator
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017

Clinical Features of Pulmonary Hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012

Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019

Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020

Prognostic value of outcome variables at follow-up in patients with PAH
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

The Role Of TGF-ß in Lung Cancer Development in COPD Patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

The Analysis Of Pulmonary Risk Factors In Preoperative Evaluation
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017

Prognostic Factors for Mortality in Chronic Pulmonary Aspergillosis -Experience in Japan-
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021

Effect of Pulmonary Rehabilitation on Functional Exercise Capacity and Hypoxemia in Patients with Interstitial Lung Diseases: a retrospective study
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019

Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Effects of Thoracic Mobilization Techniques on Pulmonary Functions, Dyspnea and Health Status in Patients with Asthma
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019

Interdisciplinary Pilot Project on Emphysema Quantification and Bronchial Wall Thickness assessment in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Patterns of Oxygen Pulse Response to Incremental Exercise in Patients with Chronic Obstructive Pulmonary Disease – An Observational Study
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017

Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019

Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017